APP and Alzheimer disease: Hence, we performed a preliminary study on the effects of post-treatment withginkgolide (Baiyu®) and its components (ginkgolide B and bilobalide) on cell viability in an AD cellular model involving an APP/PS1 double gene-transfected HEK293 cell line (APP/PS1-HEK293), in order to initially assess the efficacy of this agent in the cell model, and further explored the related mechanisms of action.